JW Pharmaceutical Corporation

KSE 001060.KS

JW Pharmaceutical Corporation Shares (Diluted, Weighted) for the year ending December 31, 2023: 24,605,275

JW Pharmaceutical Corporation Shares (Diluted, Weighted) is 24,605,275 for the year ending December 31, 2023, a 2.86% change year over year. Shares (diluted, weighted) are the number of outstanding shares used to calculate earnings per share (EPS) assuming the conversion of all potentially dilutive securities.

JW Pharmaceutical Corporation Shares (Diluted, Weighted) for the year ending December 31, 2022 was 23,922,227, a 3.08% change year over year.
JW Pharmaceutical Corporation Shares (Diluted, Weighted) for the year ending December 31, 2021 was 23,208,053, a -0.05% change year over year.
JW Pharmaceutical Corporation Shares (Diluted, Weighted) for the year ending December 31, 2020 was 23,220,415, a 0.04% change year over year.
JW Pharmaceutical Corporation Shares (Diluted, Weighted) for the year ending December 31, 2019 was 23,210,881, a -14.00% change year over year.

Key data

Date	Shares (Diluted, Weighted)	Revenue	Cost of Revenue	Gross Profit

KSE: 001060.KS

JW Pharmaceutical Corporation

CEO	Mr. Young-Sub Shin
IPO Date	Sept. 29, 2005
Location	South Korea
Headquarters	2477, Nambusunhwan-ro
Employees	1,064
Sector	Health Care
Industries Pharmaceuticals Drugstores & Retail Pharmacies

Description

JW Pharmaceutical Corporation develops, manufactures, and sells medicines and medical supplies in Japan and internationally. It offers products in the areas of cardiovascular, gastrointestinal, urinary, oral hypoglycemic, antibiotics, anti-fungal, Ob and Gy, renal, CNS, anti-anemic, respiratory, rheumatic arthritis, anticancer, anesthetic, antidotes, amino acids, TPN, and others. The company was founded in 1945 and is headquartered in Seoul, South Korea.

Key trends

Past 5 years